- Home
- FLNT vs ABVC Comparison
FLNT vs ABVC Comparison
Compare FLNT & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- ABVC
- Stock Information
- Founded
- FLNT 2001
- ABVC 2015
- Country
- FLNT United States
- ABVC United States
- Employees
- FLNT N/A
- ABVC N/A
- Industry
- FLNT Advertising
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- ABVC Health Care
- Exchange
- FLNT Nasdaq
- ABVC Nasdaq
- Market Cap
- FLNT 65.0M
- ABVC 68.7M
- IPO Year
- FLNT N/A
- ABVC N/A
- Fundamental
- Price
- FLNT $1.97
- ABVC $2.95
- Analyst Decision
- FLNT Hold
- ABVC
- Analyst Count
- FLNT 1
- ABVC 0
- Target Price
- FLNT $2.50
- ABVC N/A
- AVG Volume (30 Days)
- FLNT 23.1K
- ABVC 62.9K
- Earning Date
- FLNT 11-13-2025
- ABVC 11-03-2025
- Dividend Yield
- FLNT N/A
- ABVC N/A
- EPS Growth
- FLNT N/A
- ABVC N/A
- EPS
- FLNT N/A
- ABVC N/A
- Revenue
- FLNT $212,352,000.00
- ABVC $797,916.00
- Revenue This Year
- FLNT N/A
- ABVC $735.18
- Revenue Next Year
- FLNT $9.90
- ABVC N/A
- P/E Ratio
- FLNT N/A
- ABVC N/A
- Revenue Growth
- FLNT N/A
- ABVC 56.52
- 52 Week Low
- FLNT $1.50
- ABVC $0.40
- 52 Week High
- FLNT $3.46
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- FLNT 36.83
- ABVC 51.04
- Support Level
- FLNT $2.07
- ABVC $2.77
- Resistance Level
- FLNT $2.02
- ABVC $2.95
- Average True Range (ATR)
- FLNT 0.07
- ABVC 0.16
- MACD
- FLNT -0.01
- ABVC 0.01
- Stochastic Oscillator
- FLNT 17.71
- ABVC 64.29
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.